Troy Wilson, Ph.D., J.D.

President and Chief Executive Officer

Troy Wilson, Ph.D., J.D., is one of Kura’s co-founders and has served as our President and Chief Executive Officer and as a member of our board of directors since our inception in August 2014. Previously, Dr. Wilson was co-founder, President and Chief Executive Officer and a member of the board of directors of Intellikine, Inc., a privately held company focused on the discovery and development of innovative, small molecule drugs for the treatment of cancer, from 2007 until its acquisition in December 2011 by Takeda Pharmaceuticals. He is currently a member of the board of directors of public companies Puma Biotechnology, Inc. (Nasdaq: PBYI) and Zosano Pharma, Inc. (Nasdaq: ZSAN). Dr. Wilson also serves as President and Chief Executive Officer and a member of the board of managers of private companies Wellspring Biosciences Inc., Araxes Pharma LLC and Avidity Biosciences LLC. He obtained a J.D. from New York University and graduated with a Ph.D. in bioorganic chemistry and a B.A. in biophysics from the University of California, Berkeley.